 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 2002, 22(7):2451-2459
The Age-Related Decrease in CNS Remyelination Efficiency Is
Attributable to an Impairment of Both Oligodendrocyte Progenitor
Recruitment and Differentiation
Fraser J.
Sim1, 2,
Chao
Zhao1,
Jacques
Penderis1, 3, and
Robin J. M.
Franklin1
1 Department of Clinical Veterinary Medicine,
University of Cambridge, Cambridge CB3 0ES, United Kingdom,
2 Department of Anatomy, University of Cambridge,
Cambridge, CB2 3DY, United Kingdom, 3 Animal Health Trust,
Kentford, Newmarket CB8 7UU, United Kingdom
The age-associated decrease in the efficiency of CNS remyelination
has clear implications for recovery from demyelinating diseases such as
multiple sclerosis (MS) that may last for several decades. Developing
strategies to reverse the age-associated decline requires the
identification of how the regenerative process is impaired. We
addressed whether remyelination becomes slower because of an impairment
of recruitment of oligodendrocyte progenitors (OPs) or, as is the case
in some MS lesions, an impairment of OP differentiation into
remyelinating oligodendrocytes. The OP response during remyelination of
focal, toxin-induced CNS demyelination in young and old rats was
compared by in situ hybridization using probes to two
OP-expressed mRNA species: platelet-derived growth factor- receptor
and the OP transcription factor myelin transcription factor 1 (MyT1). We found that the expression patterns for the two OP markers
are very similar and reveal a delay in the colonization of the
demyelinated focus with OPs in the old animals compared with the young
animals. By comparing the mRNA expression pattern of MyT1 with that of
the myelin proteins myelin basic protein and Gtx, we found that
in the old animals there is also a delay in OP differentiation that
increases with longer survival times. These results indicate that the
age-associated decrease in remyelination efficiency occurs because of
an impairment of OP recruitment and the subsequent differentiation of
the OPs into remyelinating oligodendrocytes, and that strategies
aimed at ameliorating the age-associated decline in remyelination
efficiency will therefore need to promote both components of the
regenerative process.
Key words:
aging; demyelination; remyelination; in
situ hybridization; oligodendrocyte progenitor; myelin
transcription factor 1; platelet-derived growth factor receptor
Copyright © 2002 Society for Neuroscience 0270-6474/02/2272451-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
O. Einstein, Y. Friedman-Levi, N. Grigoriadis, and T. Ben-Hur
Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration
J. Neurosci.,
December 16, 2009;
29(50):
15694 - 15702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Goldschmidt, J. Antel, F. B. Konig, W. Bruck, and T. Kuhlmann
Remyelination capacity of the MS brain decreases with disease chronicity
Neurology,
June 2, 2009;
72(22):
1914 - 1921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Neumann, M. R. Kotter, and R. J. M. Franklin
Debris clearance by microglia: an essential link between degeneration and regeneration
Brain,
February 1, 2009;
132(2):
288 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Baer, Y. A. Syed, S. U. Kang, D. Mitteregger, R. Vig, C. ffrench-Constant, R. J. M. Franklin, F. Altmann, G. Lubec, and M. R. Kotter
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling
Brain,
February 1, 2009;
132(2):
465 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Buckley, P. Goldsmith, and R. J. M. Franklin
Zebrafish myelination: a transparent model for remyelination?
Dis. Model. Mech.,
November 1, 2008;
1(4-5):
221 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Koch, M Uyttenboogaart, A van Harten, and J De Keyser
Factors associated with the risk of secondary progression in multiple sclerosis
Multiple Sclerosis,
July 1, 2008;
14(6):
799 - 803.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki
From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
Brain,
July 1, 2008;
131(7):
1686 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Irvine and W. F. Blakemore
Remyelination protects axons from demyelination-associated axon degeneration
Brain,
June 1, 2008;
131(6):
1464 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chandran, D. Hunt, A. Joannides, C. Zhao, A. Compston, and R. J.M Franklin
Myelin repair: the role of stem and precursor cells in multiple sclerosis
Phil Trans R Soc B,
January 12, 2008;
363(1489):
171 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Herrero-Herranz, L. A. Pardo, G. Bunt, R. Gold, W. Stuhmer, and R. A. Linker
Re-Expression of a Developmentally Restricted Potassium Channel in Autoimmune Demyelination: Kv1.4 Is Implicated in Oligodendroglial Proliferation
Am. J. Pathol.,
August 1, 2007;
171(2):
589 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev.,
June 1, 2007;
28(4):
387 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Stankoff, S. Mrejen, A. Tourbah, B. Fontaine, O. Lyon-Caen, C. Lubetzki, and M. Rosenheim
Age at onset determines the occurrence of the progressive phase of multiple sclerosis
Neurology,
March 6, 2007;
68(10):
779 - 781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tremlett and V. Devonshire
Is late-onset multiple sclerosis associated with a worse outcome?
Neurology,
September 26, 2006;
67(6):
954 - 959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Confavreux and S. Vukusic
Age at disability milestones in multiple sclerosis
Brain,
March 1, 2006;
129(3):
595 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Kotter, W.-W. Li, C. Zhao, and R. J. M. Franklin
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
J. Neurosci.,
January 4, 2006;
26(1):
328 - 332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Imitola, T. Chitnis, and S. J. Khoury
Insights Into the Molecular Pathogenesis of Progression in Multiple Sclerosis: Potential Implications for Future Therapies
Arch Neurol,
January 1, 2006;
63(1):
25 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Paintlia, M. K. Paintlia, M. Khan, T. Vollmer, A. K. Singh, and I. Singh
HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis
FASEB J,
September 1, 2005;
19(11):
1407 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Cao, X.-M. Xu, W. H. DeVries, G. U. Enzmann, P. Ping, P. Tsoulfas, P. M. Wood, M. B. Bunge, and S. R. Whittemore
Functional Recovery in Traumatic Spinal Cord Injury after Transplantation of Multineurotrophin-Expressing Glial-Restricted Precursor Cells
J. Neurosci.,
July 27, 2005;
25(30):
6947 - 6957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jaillard, S. Harrison, B. Stankoff, M. S. Aigrot, A. R. Calver, G. Duddy, F. S. Walsh, M. N. Pangalos, N. Arimura, K. Kaibuchi, et al.
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
J. Neurosci.,
February 9, 2005;
25(6):
1459 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Stidworthy, S. Genoud, W.-W. Li, D. P. Leone, N. Mantei, U. Suter, and R. J. M. Franklin
Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination
Brain,
September 1, 2004;
127(9):
1928 - 1941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Mason, A. Toews, J. D. Hostettler, P. Morell, K. Suzuki, J. E. Goldman, and G. K. Matsushima
Oligodendrocytes and Progenitors Become Progressively Depleted within Chronically Demyelinated Lesions
Am. J. Pathol.,
May 1, 2004;
164(5):
1673 - 1682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Penderis, S. A. Shields, and R. J. M. Franklin
Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system
Brain,
June 1, 2003;
126(6):
1382 - 1391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Belachew, A. A. Aguirre, H. Wang, F. Vautier, X. Yuan, S. Anderson, M. Kirby, and V. Gallo
Cyclin-Dependent Kinase-2 Controls Oligodendrocyte Progenitor Cell Cycle Progression and Is Downregulated in Adult Oligodendrocyte Progenitors
J. Neurosci.,
October 1, 2002;
22(19):
8553 - 8562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D M Chari and W F Blakemore
New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation
Multiple Sclerosis,
August 1, 2002;
8(4):
271 - 277.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jasmin and P. T. Ohara
Remyelination within the CNS: Do Schwann Cells Pave the Way for Oligodendrocytes?
Neuroscientist,
June 1, 2002;
8(3):
198 - 203.
[Abstract]
[PDF]
|
 |
|
|